A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation

Autor: Koushik Roy, Alexander Hoffmann, Sho Ohta, Stephen L. Nutt, Yi Liu, Marie Oliver Metzig, Yu-sheng Lin, Simon Mitchell
Rok vydání: 2019
Předmět:
0301 basic medicine
Cell
Inbred C57BL
Lymphocyte Activation
Mice
0302 clinical medicine
Plasma cell differentiation
2.1 Biological and endogenous factors
Immunology and Allergy
Aetiology
B-Lymphocytes
education.field_of_study
NF-kappa B
Humoral
antibody-secreting cells
Cell Differentiation
differentiation
Phenotype
Cell biology
Infectious Diseases
medicine.anatomical_structure
030220 oncology & carcinogenesis
Female
multi-scale model
Blimp1
proliferation
1.1 Normal biological development and functioning
Immunology
Population
Biology
mutual antagonism
Article
Cell Line
03 medical and health sciences
Underpinning research
medicine
Animals
Humans
Antibody-Producing Cells
education
Psychological repression
Transcription factor
B cell
Cell Proliferation
B cells
Immunity
Stem Cell Research
Immunity
Humoral

Mice
Inbred C57BL

HEK293 Cells
030104 developmental biology
Gene Expression Regulation
Humoral immunity
Generic health relevance
NFκB
Zdroj: Immunity, vol 50, iss 3
ISSN: 1074-7613
DOI: 10.1016/j.immuni.2019.02.004
Popis: Humoral immunity depends on efficient activation of B-cells and their subsequent differentiation to antibody secreting cells (ASCs). The transcription factor NFκB cRel is critical for B-cell proliferation, but incorporating its known regulatory interactions into a mathematical model of the ASC differentiation circuit prevented ASC generation in simulations. Indeed, in experimental studies cRel was dynamically repressed during ASC differentiation, and ectopic cRel expression blocked ASC differentiation by inhibiting the transcription factor Blimp1. Conversely, after Blimp1 is induced in ASCs, it represses cRel by binding the Rel locus. Including this bi-stable circuit of mutual cRel-Blimp1 antagonism into a multi-scale model revealed that dynamic repression of cRel controls the switch from B-cell proliferation to ASC generation phases and hence the respective cell population dynamics. Our studies provide a mechanistic explanation of how dysregulation of this bi-stable circuit may result in pathologic B-cell population phenotypes and present avenues for diagnostic stratification and treatment. SUGGESTED REVISION: Precise regulation of transcription factor NFkB mediates efficient activation of B-cells and their subsequent differentiation to antibody secreting cells (ASCs). To obtain a quantitative understanding of how specific NFκB dimers control ASC differentiation, we developed a mathematical model that investigated NFkB subunits cRel and RelA as distinct regulators. This model predicted that cRel inhibits ASC generation. Indeed, cRel was dynamically repressed during ASC differentiation, and ectopic cRel expression blocked ASC differentiation by inhibiting the transcription factor Blimp1. Conversely, Blimp1 inhibited cRel expression by binding the Rel locus. Including this bi-stable circuit of mutual cRel-Blimp1 antagonism into a multi-scale model revealed that dynamic repression of cRel controls the switch from B-cell proliferation to ASC generation phases and hence the respective cell population dynamics. Our studies provide a mechanistic explanation of how dysregulation of this bi-stable circuit may result in pathologic B-cell population phenotypes and present avenues for diagnostic stratification and treatment.
Databáze: OpenAIRE